Clinical Assessment & Management Analysis

Patient Summary

• 17-year-old male, mixed P. falciparum + P. vivax infection
• BP 90/60 mmHg | HR 140/min | RR 26/min | Temp 100°F
• Platelets 54,000/μL | Right hypochondriac pain | 2 episodes vomiting
• Conscious and coherent
• Started on: Falcigo (artesunate) IV + Doxycycline + 1L IV fluid bolus → 125 ml/hr maintenance + Paracetamol 1g

Step 1: Severity Classification — Is This Severe Malaria?

Step 2: Is Current Treatment Appropriate?

✅ Artesunate (Falcigo) IV — CORRECT and APPROPRIATE

• Standard: 2.4 mg/kg IV at 0 h, 12 h, 24 h, then once daily (for children <20 kg: 3 mg/kg/dose)
• At 17 years (assuming ~50–60 kg), dose should be ~120–144 mg per injection
• Confirm the ordered dose is weight-based

✅ Doxycycline — APPROPRIATE as partner drug

⚠️ Important: Doxycycline should ideally be given after, not concurrently with, the acute parenteral phase, or if given orally alongside, only once the patient can reliably retain oral medications (currently vomiting — hold oral doxy until vomiting controlled).

✅ IV Fluids — APPROPRIATE but needs caution

• Avoid large-volume fluid boluses in severe malaria — trials showed excess mortality with aggressive volume loading due to pulmonary edema risk
• 125 ml/hr maintenance is reasonable
• Monitor urine output closely (target ≥0.5 ml/kg/hr)
• If oliguria develops despite fluids → suspect acute kidney injury → early hemofiltration/dialysis

✅ Paracetamol 1g — APPROPRIATE for fever

Step 3: What Is Missing / Needs Attention

🔴 Anti-vivax / Radical Cure — NOT yet addressed

1. Acute phase: Artesunate covers vivax blood-stage parasites — acceptable
2. Radical cure (hypnozoites): Primaquine 0.25–0.5 mg/kg/day × 14 days is required to prevent relapse, BUT:
   • Check G6PD status FIRST before giving primaquine — hemolytic anemia risk
   • Start primaquine only after acute illness resolves and G6PD result is available
   • In G6PD deficiency: weekly primaquine 0.75 mg/kg × 8 weeks or tafenoquine (≥16 years)

🔴 Monitoring — ICU-level surveillance needed

• Hourly BP, HR, SpO₂
• 6-hourly or daily blood glucose (artesunate + falciparum → hypoglycemia risk)
• Renal function: creatinine, urea, urine output
• Blood film / RDT at 24 h, 48 h, 72 h (parasite clearance)
• LFTs (RHC pain → hepatic involvement)
• CBC daily (thrombocytopenia monitoring, hemolysis)
• Electrolytes

🔴 Manage Hypotension Actively

• If BP does not improve with 1L bolus → add vasopressor (norepinephrine) carefully
• Rule out concurrent sepsis/bacteremia — broad-spectrum antibiotics (e.g. ceftriaxone) should be considered given difficulty distinguishing severe malaria from co-existing sepsis, especially in children/adolescents (Harrison's 22E)

🟡 Anti-emetics

🟡 Platelet Transfusion

🟡 Oral Step-Down

• Once patient is stable, not vomiting, and has had ≥24h of parenteral artesunate → switch to oral ACT (e.g. artemether-lumefantrine) + complete doxycycline 7-day course
• Do not switch before 24h minimum of IV treatment regardless of clinical improvement

🟡 Avoid Adjunctive Harmful Treatments

Step 4: Summary Action Plan

Overall Verdict

Sources: Harrison's Principles of Internal Medicine 22E (2025), WHO Guidelines for Malaria (updated 2024), Swiss TPH Malaria Treatment Recommendations 2025

Role of LDH, Lactate, Electrolytes, and ABG in This Patient

1. LDH (Lactate Dehydrogenase)

Why it's elevated in malaria

• P. falciparum invades and ruptures RBCs at schizogony — each rupture releases intracellular LDH into plasma
• LDH is the most abundant enzyme in RBCs; even moderate hemolysis causes marked elevation
• Mixed infection (P. vivax also causes RBC lysis) amplifies this

• When oxygen delivery fails (as in this patient with shock: BP 90/60, HR 140), cells switch to anaerobic glycolysis → pyruvate → lactate, catalyzed by LDH
• Elevated LDH therefore also reflects end-organ hypoperfusion

What to do with it clinically

PADH — a specific complication of IV artesunate in heavy parasite loads: stored, drug-altered RBCs that initially "pitted" parasites re-enter circulation and are later destroyed by the spleen, causing a hemolytic dip at 1–3 weeks post-treatment. Monitor LDH + Hb at days 7, 14, 21.

2. Lactate

The mechanism in severe malaria

1. Cytoadherence & sequestration: Falciparum-infected RBCs express PfEMP1 and adhere to microvascular endothelium → microvascular obstruction → local tissue hypoxia → anaerobic glycolysis → lactic acidosis
2. Shock physiology: This patient's hypotension (BP 90/60) + tachycardia (HR 140) = reduced cardiac output → global oxygen delivery failure → type A lactic acidosis
3. Parasite metabolism: P. falciparum itself is an obligate lactate producer — the parasite ferments glucose at up to 75× the rate of host RBCs, directly dumping lactate into blood
4. Hepatic clearance failure: The liver is the main organ clearing lactate; hepatic involvement (this patient has RHC pain) impairs lactate clearance, worsening acidosis

Clinical interpretation

What to do

• Measure lactate NOW — this is a key prognostic marker in severe malaria
• Serial lactate at 2–4 hourly intervals — clearance of lactate (>10% fall per 2h) signals effective resuscitation
• Lactate-guided resuscitation: if lactate remains elevated despite fluids, escalate to vasopressors (norepinephrine)
• Do not use bicarbonate to treat lactic acidosis in malaria — treats the number, not the cause, and may worsen cerebral edema

3. Electrolytes

Sodium (Na⁺)

• Hyponatremia is common in severe malaria
• Mechanism: cytokine-mediated SIADH, volume redistribution, vomiting losses (this patient — 2 episodes)
• Dilutional effect from IV fluid resuscitation (1L NS given)
• Clinical risk: hyponatremia contributes to cerebral edema, seizure risk
• Target: Na 135–145 mEq/L; correct slowly if chronic

Potassium (K⁺)

• Can go either way:
  • Hyperkalemia from massive hemolysis (intracellular K⁺ release) — especially dangerous with acute kidney injury
  • Hypokalemia from vomiting, poor intake, shift into cells with insulin/glucose administration
• Must monitor — hyperkalemia + acidosis + AKI is a life-threatening triad

Bicarbonate (HCO₃⁻)

• Low HCO₃⁻ is a direct marker of metabolic acidosis severity
• Acts as buffer against lactic acid
• Level <15 mEq/L = severe acidosis; <10 mEq/L = life-threatening
• Use the HCO₃⁻ value from electrolytes to calculate anion gap (see ABG below)

Phosphate (PO₄³⁻)

• Hypophosphatemia is specifically named in Harrison's as a feature of severe malaria
• Mechanism: intracellular shift, poor intake, refeeding, tubular losses in AKI
• Severe hypophosphatemia (<1 mg/dL) → impaired ATP synthesis → muscle weakness, respiratory failure risk

Glucose

• Hypoglycemia is a major, life-threatening complication of severe malaria
• Caused by: parasite glucose consumption + quinine/artesunate-stimulated insulin secretion + impaired hepatic gluconeogenesis
• Check glucose every 4–6 hours; maintain >70 mg/dL with D10 infusion if needed

4. Arterial Blood Gas (ABG)

Expected ABG pattern in this patient

• Lactic acidosis from tissue hypoxia + parasite lactate production
• Loss of HCO₃⁻ from vomiting (partially offsetting)
• Anion gap = Na − (Cl + HCO₃); expected to be elevated (>12–14 mEq/L) → HAGMA

• RR 26 in this patient = hyperventilation — the body's attempt to blow off CO₂ and raise pH
• This is Kussmaul-type breathing when severe
• Expected PaCO₂: use Winter's formula → PaCO₂ = 1.5 × (HCO₃) + 8 ± 2
  • If actual PaCO₂ < expected → additional primary respiratory alkalosis
  • If PaCO₂ > expected → coexisting respiratory acidosis (respiratory failure — very bad sign)

• If the patient tires and cannot maintain hyperventilation → PaCO₂ rises → pH crashes
• Rising PaCO₂ with falling pH = impending respiratory failure → intubation threshold

ABG parameters and their specific roles

Action thresholds from ABG

• pH <7.2 + PaCO₂ rising: prepare for intubation / ICU escalation
• PaO₂ <60 mmHg on room air: start supplemental O₂; if not improving → face mask/HFNC
• BE < −10: aggressive fluid and lactate clearance protocol
• HCO₃ <10: severe buffer depletion — reassess resuscitation urgently

Summary: What to Order and Why

Source: Harrison's Principles of Internal Medicine 22E (2025) — "Laboratory Findings in Acute Malaria"; WHO Guidelines for Malaria 2024